We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.
We’d also like to use analytics cookies so we can understand how you use the service and make improvements.
Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.
Investors and funding
We harness the collective expertise of our network and combine it with our relentless pursuit of excellence in delivering a better, safer, more affordable, and dignified future for all.
At Concr we solve data to improve not only cancer diagnostics and treatments, but also equity of access to novel life-saving drugs for all patients.
By adapting established astrophysics algorithms to oncology, Concr created a distinct solution to overcome current data limitations.
We are proud to have a highly trained and deeply experienced team, which includes representatives from all Concr user groups.
Our partners leverage Concr advanced predictive modelling across every stage of therapeutic development to create shared value for the benefit of cancer patients.
Our cloud-based platform effectively integrates diverse data parcels to generate meaningful insights.
If you’d like more information or have an enquiry, please contact us.
